Durvalumab outcomes for patients with PD-L1 positive and negative stage III unresectable non-small cell lung cancer treated at veterans health administration facilities

被引：0
|
作者：
Burton, Elizabeth M.
Moore, Amanda
Nooruddin, Zohra
Cotarla, Ion
Simmons, Daniel
Davis, Laura
Reveles, Kelly R.
Datta, Paromita
Souza, Gabriel Roman
Irabor, Omoruyi Credit
Franklin, Kathleen
Jones, Xavier
Frei, Christopher R.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA
[3] Univ Texas Hlth San Antonio, San Antonio, TX USA
[4] AstraZeneca, Gaithersburg, MD USA
[5] Univ Texas Austin, San Antonio, TX USA
[6] South Texas Vet Hlth Care Syst, San Antonio, TX USA
[7] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18793
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer
    Shaverdian, Narek
    Offin, Michael D.
    Rimner, Andreas
    Shepherd, Annemarie F.
    Wu, Abraham J.
    Rudin, Charles M.
    Hellmann, Matthew D.
    Chaft, Jamie E.
    Gomez, Daniel R.
    RADIOTHERAPY AND ONCOLOGY, 2020, 144 : 101 - 104
  • [42] Original Research Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations
    Riudavets, Mariona
    Auclin, Edouard
    Mosteiro, Miguel
    Dempsey, Naomi
    Majem, Margarita
    Lobefaro, Riccardo
    Lopez-Castro, Rafael
    Bosch-Barrera, Joaquim
    Pilotto, Sara
    Escalera, Elena
    Tagliamento, Marco
    Mosquera, Joaquin
    Zalcman, Gerard
    Aboubakar-Nana, Frank
    Ponce, Santiago
    Dal Maso, Alessandro
    Spotti, Martina
    Mielgo-Rubio, Xabier
    Mussat, Elodie
    Reyes, Roxana
    Benitez, Jose-Carlos
    Lupinacci, Lorena
    Duchemann, Boris
    De Giglio, Andrea
    Blaquier, Juan
    Audigier-Valette, Clarisse
    Scheffler, Matthias
    Nadal, Ernest
    Lopes, Gilberto
    Signorelli, Diego
    Garcia-Campelo, Rosario
    Menis, Jessica
    Bluthgen, Virginia
    Campayo, Marc
    Recondo, Gonzalo
    Besse, Benjamin
    Planchard, David
    Mezquita, Laura
    EUROPEAN JOURNAL OF CANCER, 2022, 167 : 142 - 148
  • [43] Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
    Price, Katharine A. R.
    Azzoli, Christopher G.
    Gaspar, Laurie E.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 204 - 209
  • [44] Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
    Nicolazzo, Chiara
    Raimondi, Cristina
    Mancini, MariaLaura
    Caponnetto, Salvatore
    Gradilone, Angela
    Gandini, Orietta
    Mastromartino, Maria
    del Bene, Gabriella
    Prete, Alessandra
    Longo, Flavia
    Cortesi, Enrico
    Gazzaniga, Paola
    SCIENTIFIC REPORTS, 2016, 6
  • [45] Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
    Chiara Nicolazzo
    Cristina Raimondi
    MariaLaura Mancini
    Salvatore Caponnetto
    Angela Gradilone
    Orietta Gandini
    Maria Mastromartino
    Gabriella del Bene
    Alessandra Prete
    Flavia Longo
    Enrico Cortesi
    Paola Gazzaniga
    Scientific Reports, 6
  • [46] Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Jazieh et al
    Zheng, Jieling
    Zhang, Bin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (05)
  • [47] Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis
    Sugimoto, Takeya
    Fujimoto, Daichi
    Sato, Yuki
    Tamiya, Motohiro
    Yokoi, Takashi
    Taniguchi, Yoshihiko
    Hino, Aoi
    Hata, Akito
    Uchida, Junji
    Fukuda, Yasushi
    Hara, Satoshi
    Kanazu, Masaki
    Matsumoto, Hirotaka
    Kokubo, Masaki
    Yamamoto, Nobuyuki
    LUNG CANCER, 2022, 171 : 3 - 8
  • [48] Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
    Tomasini, Pascale
    Greillier, Laurent
    Boyer, Arnaud
    Jeanson, Arnaud
    Barlesi, Fabrice
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1032 - S1036
  • [49] Effect of delayed consolidation durvalumab and timing of treatment on survival outcomes in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT).
    Stevens, Samuel Xavier
    Nindra, Udit
    Shahnam, Adel
    Bray, Victoria Jane
    Yip, Po Yee
    Adam, Tamiem
    Lee, Jenny Hj
    Boyer, Michael J.
    Nagrial, Adnan
    Kao, Steven Chuan-Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18809 - E18809
  • [50] Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade
    Eltahir, Mohamed
    Isaksson, Johan
    Mattsson, Johanna Sofia Margareta
    Karre, Klas
    Botling, Johan
    Lord, Martin
    Mangsbo, Sara M.
    Micke, Patrick
    CANCERS, 2021, 13 (13)
12345